2003, Number 2
PDF size: 75.47 Kb.
ABSTRACTChronic granulomatous disease (CGD) is an heterogenic group of hereditary diseases characterized by inhability of the phagocitic cells to kills microorganisms. That produces granulomas in different organs, the more affected organs are limphatic nodes, skin, lungs, liver and digestive system. Treatment with gamma interferon produces good results. In this article we present a case of a three years old child with sex-linked CGD. After diagnosis and treatment. Genetic consel was also done.
Zumia A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996;23:146-158.
Baehner RL. Chronic granulomatous disease of childhood: clinical pathological, biochemical, molecular and genetic aspects of the disease. Pediatr Pathol 1990;10:143-153.
Agus S, Spektor S, Israel Z. CNS granulomatosis in a child with chronic granulomatous disease. Br J Neurosurg 2000;14:59-61.
Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 2000;137:687-693.
Landing BH, Shirkey HS. A syndrome of recurrence infection and infiltration of viscera by pigmented lipid histiocytes. Pediatrics 1957;20:431-8.
Roos D. The genetic basis of chronic granulomatous disease Immunol Rev 1994;138:121-157.
Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood 1991;77:673-686.
Ishibashi F, Mizukami T, Kanegasaki S, Motoda L, Kakinuma R, Endo F, Nunoi H. Improved superoxide-generating ability by interferon gamma due to splicing pattern change of transcripts in neutrophils from patients with a silice site mutation in CYBB gene. Blood 2001;98:436-441.
Jabado N, Casanova JL, Haddad E et al. Invasive pulmonary infection due to Scedosporum apiospermum in two children with chronic granulomatous disease. Clin Infect Dis 1998;27:1437-41.
Speert DP. Advances in Burkholderia cepacia complex. Pediatr Resp Rev 2002;3:230-235.
Dorman SE, Guide SV, Conville PS, deCarlo ES, Malech HL et al. Nocardia infection y chronic granulomatous disease. Clin Infect Dis 2002;15:390-394.
Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimetoprim-sulfametoxazol prophylaxis in the management of chronic granulomatous disease. J Infect Dis 1990;162:723-726.
The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324:509-516.
Horowitz ME, Barret AJ, Brown MR, Carter CS. et al. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med 2000;344:881-888.
Kume A, Dinauer MC. Gene therapy for chronic granulomatous disease. J Lab Clin Med 2000:135:122-128.
Ahlin EA, LarfarsG, Gyllenhamunar H et al. Neutrophils from patients with chronic granulomatous disease treated with interferon-gamma show augmented production of nitric oxide. J Invest Med.1995;43:S(2):210.